UNITED MEDICORP INC
10-Q, 1996-05-14
COMPUTER PROCESSING & DATA PREPARATION
Previous: SWIFT ENERGY INCOME PARTNERS 1987-C LTD, 10-Q, 1996-05-14
Next: UNITED INVESTORS GROWTH PROPERTIES, 10QSB, 1996-05-14



<PAGE>



                   SECURITIES AND EXCHANGE COMMISSION
                         WASHINGTON, D.C. 20549
                              ____________

                               FORM 10-Q

               QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
                 OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended
March 31, 1996                                 Commission File No.1-10418


                        UNITED MEDICORP, INC.  
          (Exact name of registrant as specified in charter)


   Delaware                                                     75-2217002
- -------------------------------          ---------------------------------
(State or other jurisdiction of          (IRS employer identification no.)
 incorporation or organization)


10210 N. Central Expressway, #400
   Dallas, Texas                                                     75231
- ---------------------------------                                    -----
(Address of principal                                           (Zip Code)
 executive offices)
 



              Registrant's telephone number, including area code:
                                  214/691-2140


Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days. Yes   X     No      

As of April 1, 1996, there were outstanding 26,310,217 shares of Common 
Stock, $.01 par value.



<PAGE>


                          UNITED MEDICORP, INC.
                              March 31, 1996

                            TABLE OF CONTENTS


PART I.  FINANCIAL INFORMATION 

 Item 1.  Financial Statements

 Consolidated Balance Sheets as of March 31, 1996
 and December 31, 1995 . . . . . . . . . . . . . . . . . . . . .3

 Consolidated Statements of Revenues and Expenses
 for the Three Months Ended March 31, 1996 and 1995. . . . . . .4

 Consolidated Statements of Cash Flows for the 
 Three Months Ended March 31, 1996 and 1995. . . . . . . . . . .5

 Notes to Consolidated Financial Statements. . . . . . . . . . .6
                               
 Item 2.  Management's Discussion and Analysis of Financial
 Condition and Results of Operations . . . . . . . . . . . . . .7

PART II.  OTHER INFORMATION

 Item 1.  Legal Proceedings  . . . . . . . . . . . . . . . . . 12
   
 Item 2.  Changes in Securities  . . . . . . . . . . . . . . . 12
 
 Item 3.  Default Upon Senior Securities . . . . . . . . . . . 12

 Item 4.  Submission of Matters to a Vote of Security 
           Holders . . . . . . . . . . . . . . . . . . . . . . 12

 Item 5.  Other Information. . . . . . . . . . . . . . . . . . 12

 Item 6.  Exhibits and Reports on Form 8-K . . . . . . . . . . 12


SIGNATURES . . . . . . . . . . . . . . . . . . . . . . . . . . 13


                                        -2-


<PAGE>



                               UNITED MEDICORP, INC.
                           CONSOLIDATED BALANCE SHEETS


<TABLE>
<CAPTION>
                                              (UNAUDITED)      (AUDITED)   
                                               MARCH 31,      DECEMBER 31, 
                                                 1996             1995     
                                              -----------     ------------ 
<S>                                           <C>            <C>
CURRENT ASSETS:
  Cash and cash equivalents                   $    70,026    $    58,078
  Accounts receivable, less allowance for
   doubtful accounts of $6,791 and $7,493,
   respectively                                   180,485        138,970
  Notes receivable, less allowance for
   doubtful accounts of $0 and $0,
   respectively                                       214            214
  Prepaid expenses and other                       17,389         20,427
                                              -----------    -----------

    TOTAL CURRENT ASSETS                          268,114        217,689

PROPERTY AND EQUIPMENT (net)                      179,909        200,996

OTHER ASSETS                                       16,855         17,373
                                              -----------    -----------

   TOTAL ASSETS                               $   464,878    $   436,058
                                              -----------    -----------
                                              -----------    -----------

CURRENT LIABILITIES:
  Payable to clients                          $    60,942    $    19,902
  Trade accounts payable                           70,901         48,230
  Accrued expenses                                137,679        141,501
  Deferred revenue                                  7,980         15,959
  Current portion of capital lease 
   obligations                                     30,320         32,487
                                              -----------    -----------

    TOTAL CURRENT LIABILITIES                     307,822        258,079

LONG TERM LEASE OBLIGATION                        126,142        138,565

DEFERRED CREDITS                                   36,996         31,434

COMMITMENTS AND CONTINGENCIES  

STOCKHOLDERS' EQUITY
  Common stock, $.01 par value; 50,000,000 
   authorized, 26,415,764 shares issued and 
   outstanding at 3/31/96 and 12/31/95.           264,157        264,157

Less: 105,547 shares of treasury stock, 
 at cost                                         (221,881)      (221,881)
Additional paid-in capital                     18,552,343     18,552,341
Retained deficit                              (18,600,701)   (18,586,637)
                                              -----------    -----------

     TOTAL STOCKHOLDERS' EQUITY                    (6,082)         7,980
                                              -----------    -----------

     TOTAL LIABILITIES AND STOCKHOLDERS' 
      EQUITY                                     $464,878       $436,058
                                              -----------    -----------
                                              -----------    -----------
</TABLE>


The accompanying notes are an integral part of these financial statements.


                                     -3-



<PAGE>


                            UNITED MEDICORP, INC.
               CONSOLIDATED STATEMENTS OF REVENUES AND EXPENSES
                                 (UNAUDITED)
<TABLE>
<CAPTION>

                                   THREE MONTHS       THREE MONTHS
                                      ENDED              ENDED
                                  MARCH 31, 1996     MARCH 31, 1995
                                  --------------     --------------
<S>                                <C>                <C>
REVENUES:
  Fee income                       $   470,365        $   588,142
  Interest income                            0              1,680
                                   -----------        -----------

    Total revenues                     470,365            589,822

EXPENSES:
  Salaries and benefits                305,075            395,313
  Selling, general and 
   administrative                      105,960            114,837
  Professional fees                     14,489             16,490
  Office and equipment rental           28,303             16,137
  Depreciation and amortization         26,034             31,481
  Interest                               4,568              7,432
                                   -----------        -----------

    TOTAL EXPENSES                     484,429            581,690
                                   -----------        -----------

NET INCOME (LOSS)                  $   (14,064)       $     8,132
                                   -----------        -----------
                                   -----------        -----------

NET INCOME (LOSS) PER SHARE        $     (0.00)       $      0.00
                                   -----------        -----------
                                   -----------        -----------

WEIGHTED AVERAGE
 COMMON SHARES OUTSTANDING          26,310,217         26,310,217
                                   -----------        -----------
                                   -----------        -----------
</TABLE>

The accompanying notes are an integral part of these financial statements.


                                     -4-



<PAGE>


                            UNITED MEDICORP, INC.
                   CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (Unaudited)

<TABLE>
<CAPTION>
                                              THREE MONTHS     THREE MONTHS   
                                                 ENDING            ENDING     
                                             MARCH 31, 1996    MARCH 31, 1995 
                                             --------------    -------------- 
<S>                                          <C>             <C>
OPERATING ACTIVITIES:
  Net income (loss)                            $ (14,064)         $  8,132 
  Adjustments to reconcile net income 
   (loss) to cash used in operating 
   activities:
     Depreciation and amortization                26,034            31,481 
     (Increase) in accounts receivable           (41,515)          (61,343)
     (Increase) in notes receivable                    0           (21,000)
     Decrease in prepaid expenses and other        3,038             7,207 
     Increase in deposits and other                    0            12,180 
     Increase in payable to clients               41,040             4,851 
     Increase (Decrease) in accounts payable      22,671           (21,062)
     Increase (Decrease) in accrued expenses      (3,822)           17,640 
     (Decrease) in deferred revenue               (7,979)                0 
     Increase (Decrease) in deferred credits       5,562           (11,745)
                                               ---------          -------- 
       Net cash provided by (used in) 
        operating activities                      30,965           (33,659)
                                               ---------          -------- 

INVESTING ACTIVITIES:
  (Additions) of property and equipment, net      (4,427)           (1,863)
                                               ---------          -------- 
    Net cash (used in) investing activities       (4,427)           (1,863)
                                               ---------          -------- 

FINANCING ACTIVITIES:
  Repayment of notes payable                           0          (200,000)
  (Decrease) in capital lease obligations        (14,590)                0 
                                               ---------          -------- 
    Net cash (used in) financing activities      (14,590)         (200,000)
                                               ---------          -------- 

INCREASE (DECREASE) IN CASH AND CASH 
 EQUIVALENTS                                      11,948          (235,522)

CASH AND CASH EQUIVALENTS, beginning of 
 period                                           58,078           351,233 
                                               ---------          -------- 

CASH AND CASH EQUIVALENTS, end of period       $  70,026          $115,711 
                                               ---------          -------- 
                                               ---------          -------- 

  Cash paid for interest                       $   4,568          $ 11,611 
                                               ---------          -------- 
                                               ---------          -------- 
</TABLE>




The accompanying notes are an integral part of these financial statements.



                                    -5-  

<PAGE>

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.  BASIS OF PREPARATION 

United Medicorp, Inc. (the "Company" or "UMC") is a publicly held company 
traded on the over the counter market under the symbol UMCI.  UMC was founded 
in March, 1989 to provide medical insurance claims management services to 
healthcare providers throughout the United States.

The accompanying consolidated financial statements as of March 31, 1996 and 
for the three month periods ended March 31, 1996 and 1995 are unaudited.  
However, in the opinion of management, all adjustments consisting of normal 
recurring adjustments necessary for the fair presentation of financial 
position, results of operations, and cash flows for the periods shown have 
been made, except the consolidated financial statements do not include any 
adjustments that might result from the uncertainty described in Note 2 below. 
Certain information and footnote disclosures normally included in financial 
statements prepared in accordance with generally accepted accounting 
principles have been omitted pursuant to the rules and regulations of the 
Securities and Exchange Commission, although management believes that the 
disclosures contained herein are adequate to make the information presented 
not misleading.  These financial statements should be read in conjunction 
with the financial statements and the notes thereto included in the Company's 
Annual Report on Form 10-K for the year ended December 31, 1995.

2.  CAPITAL INFUSION AND GOING CONCERN 

At March 31, 1996, the Company had $70,026 in cash and cash equivalents on 
hand. These funds along with forecasted revenues are projected by management 
to be adequate to fund operations through 1996.  The Company continues to 
pursue new business primarily through direct contacts with prospective 
customers in an effort to generate additional revenues.  There is no 
assurance that revenues generated from existing customers will continue as 
forecasted or that the Company will be successful in securing new customers 
or sources of revenue before the Company's remaining capital is depleted.  In 
the event such new customers or sources of revenue are not secured, 
management projects that cash flow from operations may not be sufficient to 
provide for the Company's working capital needs beyond 1996, in which case 
the Company will be required to raise additional capital in order to continue 
operating in its present form.  Due to the Company's history of operating 
losses there can be no assurance that additional investment capital can be 
raised in the event the Company is not successful in securing new customers 
or new sources of revenue.

3.  ACCOUNTS RECEIVABLE 

Accounts receivable represents fees which have been billed to and are due 
from customers. Included in the $180,485 of accounts receivable at March 31, 
1996 are $29,134 related to services rendered to Healthcare Advisory Service 
of Puerto Rico, Inc. ("HAS").  As of the date of this report, HAS cash 
reserves are zero.  The ability of HAS to pay UMC for services 


                                     -6- 

<PAGE>

rendered is contingent upon receipt by HAS of payment from its customers for 
services rendered.  There can be no assurance that such payment will be 
received, or if it will be received within the timeframe anticipated by HAS 
and UMC management.  The Company has not established any reserve for bad 
debts related to receivables due from HAS.

4.  PAYABLE TO CLIENTS

Payable to clients includes claim payments collected from insurance carriers 
on behalf of UMC customers.  These funds are remitted to customers by UMC on 
a weekly, semi-monthly, or monthly interval.  Also included in this item at 
March 31, 1996 is $26,516 received from HAS in payment of a UMC invoice for 
services rendered to the Yauco Hospital.  Due to ambiguities in the contract 
between UMC and HAS, there is a possibility that, under certain 
circumstances, HAS would demand repayment of these funds from UMC.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

U.S. OPERATIONS:  During the three months ended March 31, 1996, the Company 
completed a contract for billing and collection services for an operator of 
wound care clinics; a contract for managed care claims repricing services 
with an association of primary care physicians; and a contract for billing 
and collection services for a hospice. Once these contracts are fully ramped 
up, management's estimate of the monthly revenues from these three new 
contracts is in the range of $5K to $10K per month.

Late in the quarter, the Company was notified by its second largest customer, 
Mimbres Memorial Hospital ("MMH"), that it had accepted an offer to be 
acquired by a hospital chain. The chain has available the resources necessary 
to perform all of the billing and collection functions which had been 
outsourced to UMC. Effective April 12, 1996, MMH discontinued transmitting 
new claims to UMC for processing. MMH contributed about $360K in fees during 
1995 and $90,700 in fees during the three months ended March 31, 1996. 
Management believes that the wind down of services to MMH will generate about 
$25K to $35K in fees during the second quarter of 1996. 

PUERTO RICAN OPERATIONS:  Most of the Company's revenue in Puerto Rico is 
derived from HAS, which the Company serves as a subcontractor in regard to 
HAS' contract for claims processing services to the Administracion de 
Facilidades y Servicios de Salud ("AFASS"). Under this contract, the Company 
has provided claims processing and follow up services to eight AFASS funded 
clinics and one hospital in Yauco, Puerto Rico.

Early in the first quarter, the Company received $26,516 from a progress 
billing for services at the Yauco Hospital. Under the contract between HAS 
and AFASS, fees for the contract term 



                                    -7- 

<PAGE>

from July 1, 1995 to June 30, 1996 are computed as a percentage of the amount 
by which total collections exceed a "baseline" of $2,500,000. As of March 31, 
1996, the Company's projections based on collections and claims processed to 
date indicate that the baseline will not be attained and therefore no fees 
will be realizable from the Yauco contract when the final reconciliation of 
total collections received and fees due is completed in late 1997.

The contract between the Company and HAS is silent with respect to any 
obligation the Company may have to repay overpayments received from AFASS on 
progress billings. In addition, based on a 19 percent decline in admissions 
at the Yauco Hospital, HAS has requested a reduction in the baseline to a 
level which, if approved by AFASS, would allow UMC to recognize fee income on 
the progress payment of $26,516 already received plus additional fees of up 
to about $55K for services rendered to the Yauco Hospital during the current 
contract term. Due to the uncertainties described above, the Company has 
chosen to record the $26,516 payment mentioned above in "payable to clients" 
on the balance sheet at March 31, 1996. A response from AFASS to HAS' request 
for a reduction in the Yauco contract baseline is expected by June 1, 1996.  
The company has no basis to dtermine or predict the likely outcome of the 
request.

In March, 1996, the Company initiated claims processing services for a ninth 
AFASS funded clinic. No additional employees were hired to accomplish the 
provision of services to this clinic, and management believes that the 
incremental costs associated with this new customer will be minimal. 
Collections and fees resulting from claims submitted for this clinic are 
projected to begin late in the second quarter of 1996. After full ramp up, 
which normally requires six months, UMC has, in the past, averaged about $500 
to $1,000 per month in fees from each of the AFASS clinics served.

During the first quarter, the Company's Puerto Rican operations generated 
revenues of $32,955, direct expenses of $49,246 and negative gross margin of 
$16,291.  There can be no assurance that projected revenues from claims 
generated by these customers will continue as forecasted or that the Company 
will be successful in securing new customers in the Puerto Rican market.  In 
addition, the current contract between HAS and AFASS, pursuant to which most 
of the Company's revenues from Puerto Rican operations are generated, expires 
June 30, 1996.  There can be no assurance that this contract will be extended 
or renewed upon expiration.  

There can be no assurance that the Company's invoices to HAS for claims 
processing services rendered in Puerto Rico will be paid as expected.  The 
Company has not established any reserve for bad debts related to receivables 
due from HAS.










                                     -8- 

<PAGE>

The following table sets forth for each period indicated the volume and gross 
dollar amount of insurance claims received and fees recognized for each of 
the Company's two principal services. In general, collections on most 
healthcare providers' new claims ("Ongoing") tend to average about 25 to 80 
percent of the gross claim amount. Backlog collection ratios range from 0 to 
about 40 percent of the aggregate gross claim amount because many backlog 
claims have already been paid or denied by the insurance carriers prior to 
submission of the claims to UMC. For these previously paid claims, UMC often 
charges an administrative fee which is less than a collection fee.

                        PROCESSING VOLUME AND FEES 
<TABLE>
<CAPTION>
                                 1994                           1995                  1996   
                      -------------------------  ----------------------------------  ------- 
                      SECOND    THIRD   FOURTH    FIRST   SECOND    THIRD   FOURTH    FIRST  
                      QUARTER  QUARTER  QUARTER  QUARTER  QUARTER  QUARTER  QUARTER  QUARTER 
                      -------  -------  -------  -------  -------  -------  -------  ------- 
<S>                   <C>      <C>      <C>       <C>     <C>      <C>      <C>      <C>     
Number of Claims
Accepted for
Processing
  Ongoing              32,552   32,280   38,779   46,972   46,021   43,161   47,249   48,280   
  Backlog                  48        0    5,753        0        0        0    3,455       41   
                       ------   ------   ------   ------   ------   ------   ------   ------   
  Total                32,600   32,280   44,532   46,972   46,021   43,161   50,704   48,321   

Gross Amount of
Claims Accepted for
Processing ($000)
  Ongoing              14,935   14,280   18,571   19,182   19,999   18,791   21,660   19,923  
  Backlog                 207        0    3,362        0        0        0    1,269       17  
                       ------   ------   ------   ------   ------   ------   ------   ------  
  Total                15,142   14,280   21,933   19,182   19,199   18,791   22,929   19,940  

Collections ($000)
  Ongoing               6,516    7,336    7,851    9,270    9,883    9,613    8,694    9,020  
  Backlog                 136      194      130      272      159       28       60       70  
                       ------   ------   ------   ------   ------   ------   ------   ------  
  Total                 6,652    7,530    7,981    9,542   10,042    9,641    8,754    9,090  

Fees Earned ($000)
  Ongoing                 290      332      371      549      482      449      447      467  
  Backlog                   8       14       15       39       15        2        3        3  
                       ------   ------   ------   ------   ------   ------   ------   ------  
  Total                   298      346      386      588      497      451      450      470  

</TABLE>

For Ongoing claims, there is typically a time lag of approximately 15 to 45 
days from contract execution to computer hardware installation and training 
of customer personnel.  During this period, Company personnel survey the 
customer's existing operations and prepare for installation. Following 
installation and training of the customer's personnel, the customer begins 
entering claims and transmitting them to the Company. There is usually a time 
lag of 30 to 90 days between transmission of a claim to a third party payor 
and collection of a claim from that payor, except in Puerto Rico, where 
commercial payors often delay payment on claims for up to two years.



                                     -9- 


<PAGE>

QUARTERLY INFORMATION:  Fee income decreased $117,777 or 20 percent, from 
$588,142 for the three months ended March 31, 1995 to $470,365 for the three 
months ended March 31, 1996.  The decrease was due to decreased revenue of 
$36,830 from domestic operations and $80,947 from Puerto Rican operations. 
                                                               
For domestic operations, fee income from "Ongoing" claims processing, 
management and collection services decreased by 9 percent from $418,771 for 
the three months ended March 31, 1995 to $382,352 for the three months ended 
March 31, 1996 due primarily to reduced revenue from WHC. Backlog collection 
fees decreased by 90 percent, from $38,817 for the three months ended March 
31, 1995 to $3,804 for the three months ended March 31, 1996 due primarily to 
reduced backlog fees from MMH.  Fees from UMC's UMClaimPros interim staffing 
service increased by 111 percent from $12,582 for the three months ended 
March 31, 1995 to $26,566 for the three months ended March 31, 1996.  Patient 
billing fees increased from $0 for the three months ended March 31, 1995 to 
$7,522 for the three months ended March 31, 1996, and installation and 
training fees increased $0 for the three months ended March 31, 1995 to 
$6,900 for the three months ended March 31, 1996.  Repricing fees increased 
from $0 for the three months ended March 31, 1995 to $4,257 for the three 
months ended March 31, 1996.  

For Puerto Rican operations, the Yauco Hospital contributed $106,466 in 
revenues during the first quarter of 1995, compared to $0 in the first 
quarter of 1996.  Fees from clinics increased by 170 percent, from $7,435 for 
the three months ended March 31, 1995 to $20,097 for the three months ended 
March 31, 1996.  Physician fees increased from $0 for the three months ended 
March 31, 1995 to $4,080 for the three months ended March 31, 1996.

Salaries and benefits for the first quarter of 1996 decreased $90,237, or 23 
percent, from $395,313 for the three months ended March 31, 1995 to $305,075 
for the three months ended March 31, 1996. Total headcount decreased from 48 
at March 31, 1995 to 40 at March 31, 1996, excluding temporary and part-time 
employees.  

Selling, general and administrative expenses decreased $8,877, or 8 percent, 
from $114,837 for the three months ended March 31, 1995 to $105,960 for the 
three months ended March 31, 1996, due primarily to expenses incurred during 
the three months ended March 31, 1995 associated with the start up of the 
Company's Puerto Rico operations.  No such expenses were incurred during 
1996. 

Professional fees decreased by $2,001, or 12 percent, from $16,490 in the 
first quarter of 1995 to $14,489 in the first quarter of 1996, due to lower 
legal fees. 

Rental expense increased $12,165, or 75 percent, from $16,137 in the first 
quarter of 1995 to $28,303 in the first quarter of 1996, due to the 
expiration of deferred credits on the lease ending July 31, 1995 for the 
office space in Dallas, Texas, and increased rent for the office space in 
Ponce, Puerto Rico which began in May, 1995.



                                     -10- 


<PAGE>

Depreciation and amortization decreased $5,447, or 17 percent, from $31,481 
in the first quarter of 1995 to $26,034 in the first quarter of 1996, due 
primarily to fixed assets becoming fully depreciated.

Interest expense decreased by $2,864, or 39 percent, from $7,432 in the first 
quarter of 1995 to $4,568 in the first quarter of 1996, due to the repayment 
of a note payable to an offshore bank on February 24, 1995.


                       LIQUIDITY AND CAPITAL RESOURCES
                                                               
SOURCES OF CAPITAL:  Operating funds through March 31, 1995 have been derived 
primarily from the issuance of Common Stock ($18.8 million).  

CAPITAL EXPENDITURES:  During the first quarter of 1996, the Company made 
capital expenditures totalling $4,427 primarily for the purchase of computer 
software necessary to support the start up of new patient balance collection 
services.  As of March 31, 1996, the Company had no significant outstanding 
commitments for capital expenditures.

LIQUIDITY OUTLOOK:  At March 31, 1996, the Company had $70,026 in cash and 
cash equivalents and $180,485 in net accounts receivable.  The Company 
generated positive cash flow of $11,948 during the first quarter of 1996 
compared to negative cash flow of $235,522 during the first quarter of 1995.

There can be no assurance that the Company's invoices to HAS for claims 
processing services rendered in Puerto Rico will be paid as expected.  The 
Company has not established any reserve for bad debts related to receivables 
due from HAS.  

During the first quarter of 1996, the Company attempted to complete an 
offering of a new class of preferred stock to a number of investors, 
including British investors who had previously invested in private placements 
of the Company's Common Stock.  The offering was not successful.

Although the Company generated positive cash flow during the first quarter of 
1996, there are considerable risks, including primarily the need for 
additional sustainable revenues, that additional capital will be needed.  
There can be no assurance that such capital will be available, or of the 
terms upon which such capital might be made available.  Additionally, UMC has 
incurred cumulative losses of $18,600,701 since inception.  These factors 
raise substantial doubt as to the Company's ability to continue as a going 
concern.







                                     -11- 

<PAGE>

                             UNITED MEDICORP, INC.

                          PART II.  OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

The Company is the defendant in a lawsuit filed on March 2, 1995 by a former 
employee of the Company.  The lawsuit charges the Company with wrongful 
discharge.  The former employee seeks unspecified past and future economic 
loss, damages, exemplary damages, reinstatement, attorney's fees and 
interest.  The plaintiff has requested a trial by jury.  Management believes 
this lawsuit to be without merit and intends to vigorously defend against the 
claim.

ITEM 2.  CHANGES IN SECURITIES

     Not applicable.

ITEM 3.  DEFAULT UPON SENIOR SECURITIES

     Not applicable.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     Not applicable.

ITEM 5.  OTHER INFORMATION

     Not applicable.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     Not applicable.





                                     -12- 

<PAGE>

                                  SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this Quarterly Report to be signed on its behalf 
by the undersigned, thereunto duly authorized.

                                       UNITED MEDICORP, INC.
                                       (Registrant)

By: /s/  PETER W. SEAMAN                          Date:  May 9, 1996 
   ---------------------------------                     ----------- 
    Peter W. Seaman, President and
    Chief Executive Officer
    (Principal Accounting Officer)                                  














                                     -13- 



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                          76,026
<SECURITIES>                                         0
<RECEIVABLES>                                  180,699
<ALLOWANCES>                                     6,791
<INVENTORY>                                          0
<CURRENT-ASSETS>                               268,114
<PP&E>                                         179,909
<DEPRECIATION>                                  26,034
<TOTAL-ASSETS>                                 464,878
<CURRENT-LIABILITIES>                          307,822
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       264,157
<OTHER-SE>                                   (227,963)
<TOTAL-LIABILITY-AND-EQUITY>                   464,878
<SALES>                                              0
<TOTAL-REVENUES>                               470,365
<CGS>                                                0
<TOTAL-COSTS>                                  484,429
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,568      
<INCOME-PRETAX>                               (14,064)
<INCOME-TAX>                                         0                      
<INCOME-CONTINUING>                           (14,064)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (14,064)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission